Chugai Venture Fund

Funding rounds backed by Chugai Venture Fund.

Export CSV
Funding disclosed in full
$75M
Median round
$37.5M
Rounds in calculation
2
2 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Leal Therapeutics

Develops neuro-metabolic therapeutics for schizophrenia and ALS

$30MSeries ABiotechUnited States
8 participantsAlexandria Venture InvestmentsChugai Venture FundEli Lilly and CompanyEuclidean CapitalNewpath PartnersOrbiMedPhiFundSV Health Investors' Dementia Discovery Fund
Ten63 Therapeutics

Develops AI-driven drug discovery platform for first- and best-in-class therapeutics

$45MStrategicAIUnited States
14 participantsAlexandria Venture InvestmentsBlack Opal VenturesCape Fear BioCapitalChugai Venture FundDraper AssociatesDuke Capital PartnersGates FoundationHatteras Venture PartnersK5 GlobalMorpheus VenturesPanoramaRYSESF HoldingsYosemite